ETF Holdings Breakdown of AVXL

News associated with AVXL

Cetera Investment Advisers Takes $150,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)

Cetera Investment Advisers bought a new stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 14,001 shares of the biotechnology company’s stock, valued at approximately $150,000. Several other hedge […] - 2025-06-03 09:22:58

Squarepoint Ops LLC Boosts Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)

Squarepoint Ops LLC raised its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 304.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 67,627 shares of the biotechnology company’s stock after purchasing an additional 50,924 shares during the period. Squarepoint Ops LLC owned […] - 2025-06-03 08:38:51

Bank of America Corp DE Has $2.14 Million Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)

Bank of America Corp DE cut its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 27.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 198,780 shares of the biotechnology company’s stock after selling 76,485 shares during the quarter. Bank of America Corp DE’s holdings in Anavex Life Sciences were worth $2,135,000 […] - 2025-06-03 08:04:52

MetLife Investment Management LLC Has $496,000 Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)

MetLife Investment Management LLC grew its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 14.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,177 shares of the biotechnology company’s stock after acquiring an additional 5,816 […] - 2025-05-06 08:01:07

AlphaQuest LLC Acquires Shares of 13,626 Anavex Life Sciences Corp. (NASDAQ:AVXL)

AlphaQuest LLC acquired a new stake in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 13,626 shares of the biotechnology company’s stock, valued at approximately $146,000. Several other hedge funds and […] - 2025-03-18 08:06:52

19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Proficio Capital Partners LLC

Proficio Capital Partners LLC bought a new position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 19,558 shares of the biotechnology company’s stock, valued at approximately $210,000. Several other hedge funds and other institutional investors have also recently modified their holdings of […] - 2025-03-13 07:14:57

Y Intercept Hong Kong Ltd Buys New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)

Y Intercept Hong Kong Ltd purchased a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 22,631 shares of the biotechnology company’s stock, valued at approximately $243,000. Other large investors also recently made changes to their positions in the company. Barclays PLC lifted its […] - 2025-03-05 10:19:04

Anavex Life Sciences (NASDAQ:AVXL) vs. Cortexyme (NASDAQ:CRTX) Financial Survey

Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Cortexyme (NASDAQ:CRTX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Valuation & Earnings This table compares Anavex […] - 2025-02-28 07:00:47

HC Wainwright Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL)

Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 382.48% from the […] - 2025-02-20 07:14:43

Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Purchased by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. boosted its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,980 shares of the biotechnology company’s stock after acquiring […] - 2025-02-04 09:46:55

SG Americas Securities LLC Has $374,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)

SG Americas Securities LLC lifted its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 25.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,844 shares of the biotechnology company’s stock after buying an additional 7,138 shares during the period. […] - 2025-02-04 08:55:00

AVXL institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	44,090	USD 421,941
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	44,090	USD 421,941
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	53,002	USD 507,229
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	44,859	USD 429,301
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,489	USD 14,250
Total =		187,530	USD 1,794,662

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer